APA (7th ed.) Citation

Gutierrez-Aguirre, C., Cantu-Rodriguez, O., Gonzalez-Llano, O., Jaime-Perez, J., Mancias-Guerra, C., Flores-Jimenez, J., . . . Gomez-Almaguer, D. (2012). Therapy of Steroid-Refractory Chronic GVHD with Subcutaneous Low-Dose Alemtuzumab and Rituximab Combination Is Effective and Safe. Biology of Blood & Marrow Transplantation, 18(2), S366. https://doi.org/10.1016/j.bbmt.2011.12.432

Chicago Style (17th ed.) Citation

Gutierrez-Aguirre, C.H, O.G Cantu-Rodriguez, O. Gonzalez-Llano, J.C Jaime-Perez, C. Mancias-Guerra, J.A Flores-Jimenez, J. Alatorre-Ricardo, and D. Gomez-Almaguer. "Therapy of Steroid-Refractory Chronic GVHD with Subcutaneous Low-Dose Alemtuzumab and Rituximab Combination Is Effective and Safe." Biology of Blood & Marrow Transplantation 18, no. 2 (2012): S366. https://doi.org/10.1016/j.bbmt.2011.12.432.

MLA (9th ed.) Citation

Gutierrez-Aguirre, C.H, et al. "Therapy of Steroid-Refractory Chronic GVHD with Subcutaneous Low-Dose Alemtuzumab and Rituximab Combination Is Effective and Safe." Biology of Blood & Marrow Transplantation, vol. 18, no. 2, 2012, p. S366, https://doi.org/10.1016/j.bbmt.2011.12.432.